ClinicalTrials.gov
public full text
Public Domain
The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk
This is a two-cohort (screen naïve vs screen established), prospective, longitudinal, single-center clinical study design that will provide data to comprehensively evaluate patient-reported outcomes of Artificial Intelligence (AI) based prediction of an individual's risk of developing lung cancer over the next 3 years.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Understanding Lung Cancer Related Risk Factors and Their Impact#1046509
- Predicthor: AI-Powered Predictive Risk Model for 30-Day Mortality and 30-Day Complications in Patients Undergoing Thoracic Surgery for Lung Cancer#20664
- AI-driven integration of genomic and exposome data for cancer risk: the combined risk score (CRS).#309109
- Artificial intelligence and machine learning in non-small cell lung cancer: the current state of the science on multi-omic applications.#25830
- Quality of Life as a Predictor of OS and PFS in Patients With Lung Cancer#1161765
Record · ID 860962
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive